Overview
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility
Inclusion Criteria:
- cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement
Exclusion Criteria:
- anticoagulation therapy intolerant
- active endocarditis
- anatomical or medical, surgical, psychological or social contraindications